Rob Lankin is a technology entrepreneur with 17 years experience in high technology systems development and commercialization.  As Founder and CEO, he grew two high technology companies from concept through volume production of advanced control systems for Global 2000 corporations.  Mr. Lankin, M.Sc., P.Eng., is the inventor or co-inventor of a dozen patents.

Ezra Lwowski was formerly Head of Biotech & Healthcare Investment Banking at Harris Partners, and Vice President & Director, Senior Analyst, and Healthcare and Biotechnology Strategist at Orion Securities (Yorkton). Dr. Lwowski holds an MBA in Finance and a PhD in Physiology.

Bruno Maruzzo is a technology consultant with over 20 years experience working with companies in the computer, electronics and biotechnology fields as well as working in venture capital investing in technology oriented companies. Mr. Maruzzo holds a BASc in Electrical Engineering, an MASc in Biomedical Engineering and an MBA.

John Simard is a biotechnology entrepreneur. He was the founder and Chief Executive Officer (1997-2002) of CTL ImmunoTherapies Corporation and a co-founder of AlleCure Corporation, both of California. These two companies were merged into MannKind Corporation that successfully completed its IPO in July 2004 (NASDAQ “MNKD”). Previously, Mr. Simard was with the Amgen Research Institute where he co-authored a textbook on immunology entitled “Handbook of Immune Response Genes.”

John Sinton is a technology entrepreneur. He is the founder and Chief Executive Officer Autobranch Technologies, a software company, has 20 years experience in creating new ventures in electronics, software and medical technology. He was formerly the Director of Engineering for the laboratory automation division of MDS Inc. Mr. Sinton holds masters degrees in business and electrical engineering.